<- Go Home
Neuronetics, Inc.
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Market Cap
$232.3M
Volume
293.2K
Cash and Equivalents
$18.5M
EBITDA
-$32.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$54.8M
Profit Margin
73.12%
52 Week High
$5.92
52 Week Low
$0.52
Dividend
N/A
Price / Book Value
7.09
Price / Earnings
-2.56
Price / Tangible Book Value
-17.98
Enterprise Value
$300.6M
Enterprise Value / EBITDA
-9.70
Operating Income
-$34.0M
Return on Equity
132.53%
Return on Assets
-16.54
Cash and Short Term Investments
$18.5M
Debt
$82.6M
Equity
$31.8M
Revenue
$74.9M
Unlevered FCF
-$13.1M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium